ArticleBMC medical imaging2026
Diagnostic performance of ultrasonography in predicting extrathyroidal extension in papillary thyroid carcinoma.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionExtrathyroidal extension (ETE) is a critical prognostic factor influencing treatment decisions in papillary thyroid carcinoma (PTC). While ultrasonography (US) is widely used for preoperative ETE assessment, its diagnostic accuracy varies across anatomical sites and tumor characteristics. This study evaluates the performance of US in predicting pathologic ETE in PTC, focusing on strap muscle, tracheal, and recurrent laryngeal nerve (RLN) invasion, stratified by tumor size, histopathology, and molecular profile.
methodsA retrospective analysis of surgically treated PTC patients was conducted. Sonographic features assessed included capsular disruption, strap muscle replacement, tumor-trachea angle, and RLN protrusion into the tracheoesophageal groove (TEG). Diagnostic performance was measured via sensitivity, specificity, positive (PPV) and negative predictive values (NPV), with subgroup analyses based on tumor size, histologic risk, and genetic alterations.
resultsIn total, 1625 patients were analyzed. For strap muscle invasion, the feature of strap muscle replacement demonstrated high specificity (96.6%) and a PPV that increased with tumor size, reaching 75.9% in tumors > 3 cm. This PPV was further elevated to 87.5% in tumors with high-risk BRAF + TERT co-mutations. For tracheal invasion, an obtuse tumor-trachea angle was the most accurate predictor, maintaining a high PPV across all tumor sizes (85.7% in ≤ 1 cm tumors). RLN involvement was best predicted by protrusion into the tracheoesophageal groove, which showed high sensitivity (83.3%) but a modest PPV (25.6%). Molecular stratification revealed that BRAF + TERT co-mutations were consistently associated with a higher PPV for ETE across all sites, despite a lower sensitivity.
conclusionSonographic features like strap muscle replacement and obtuse tumor-trachea angles are highly specific for ETE and should strongly guide surgical planning. The assessment of RLN invasion, while sensitive, requires caution due to a high false-positive rate. Molecular profiling, particularly for BRAF + TERT co-mutations, significantly enhances risk stratification, underscoring the value of a tailored, multi-parameter preoperative evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.